Cargando…
Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome
BACKGROUND: Gliomas are the most common human brain tumors. Glioblastoma, also known as glioblastoma multiform (GBM), is the most aggressive, malignant, and lethal glioma. The investigation of prognostic and diagnostic molecular biomarkers in glioma patients to provide direction on clinical practice...
Autores principales: | Bai, Yu, Zhang, Quan-Geng, Wang, Xin-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279594/ https://www.ncbi.nlm.nih.gov/pubmed/25498217 http://dx.doi.org/10.1186/s40001-014-0066-4 |
Ejemplares similares
-
TEs or not TEs? That is the evolutionary question
por: Vaknin, Keren, et al.
Publicado: (2009) -
Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification
por: Liu, Zhao, et al.
Publicado: (2021) -
DNA hypermethylation markers of poor outcome in laryngeal cancer
por: Stephen, Josena K., et al.
Publicado: (2010) -
Downregulation of ADAMTS8 by DNA Hypermethylation in Gastric Cancer and Its Clinical Significance
por: Chen, Jing, et al.
Publicado: (2016) -
The serodiagnostic potential of recombinant proteins TES–30 and TES–120 in an indirect ELISA in the diagnosis of toxocariasis in cattle, horses, and sheep
por: dos Santos, Lucas Moreira, et al.
Publicado: (2019)